
Rexulti: Uses, Dosage, Side Effects, Warnings - Drugs.com
Jun 30, 2025 · Rexulti is an antipsychotic used to treat major depressive disorder, schizophrenia, or agitation associated with dementia due to Alzheimer’s disease. It is an oral tablet that is taken once a …
Brexpiprazole - Wikipedia
Brexpiprazole, sold under the brand name Rexulti among others, is an atypical antipsychotic medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with …
REXULTI® (brexpiprazole) | Patient Information Website
Learn about REXULTI® (brexpiprazole), its uses and how it may help. See Important Safety Info & Full Prescribing Info, including Boxed WARNING.
Rexulti (brexpiprazole) - Uses, Side Effects, and More
Jun 26, 2024 · Rexulti is an antipsychotic medicine that helps to balance chemicals in the brain called dopamine and serotonin. These chemicals are known to affect mood and thoughts.
Rexulti (Brexpiprazole Tablets): Side Effects, Uses, Dosage ...
May 20, 2025 · Rexulti (Brexpiprazole Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …
The most common side effects of REXULTI in adults include weight gain, sleepiness, dizziness, common cold symptoms, and restlessness or feeling like you need to move (akathisia).
Rexulti: Uses, drug class, alternatives, and more
May 28, 2025 · Rexulti (brexpiprazole) is used to treat schizophrenia, depression, and agitation related to dementia. Learn about side effects, dosage, and more.
Brexpiprazole (oral route) - Side effects & dosage - Mayo Clinic
Sep 27, 2015 · Brexpiprazole is used to treat mental conditions, including depression and schizophrenia. It is also used to treat agitation that may happen with dementia caused by Alzheimer's disease. …
Rexulti: Depression Uses, Side Effects, Dosage - MedicineNet
Rexulti (brexpiprazole) is an antidepressant used to treat major depressive disorder (MDD), schizophrenia, and agitation associated with dementia due to Alzheimer's disease. Rexulti is used as …
Adverse reactions associated with REXULTI (incidence of 2% or greater and REXULTI incidence greater than placebo) during short-term (up to 6-weeks) trials in patients with schizophrenia are...